SRL
GPCR icon

Scientech Research LLC’s Structure Therapeutics GPCR Stock Holding History

Scientech Research LLC’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,958
Closed -$335K – 367
2026
Q1 		$335K Buy
+6,958
New +$476K 0.28% 104
2024
Q3 		– Sell
-18,803
Closed -$738K – 698
2024
Q2 		$738K Buy
+18,803
New +$772K 0.15% 245

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Scientech Research LLC's GPCR Position: Q2 2026 in Review

Scientech Research LLC sold out of Structure Therapeutics (GPCR) in Q2 2026, closing a stake of 6,958 shares — an estimated $335K sold.

Scientech Research LLC first reported a position in GPCR in Q2 2024 and held it in 2 quarters. The position peaked at $738K in Q2 2024. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Scientech Research LLC reported no remaining Structure Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Scientech Research LLC sold 6,958 Structure Therapeutics shares in Q2 2026, an estimated $335K.
  • Scientech Research LLC first reported a position in Structure Therapeutics in Q2 2024 and held it in 2 quarters.
  • Scientech Research LLC's Structure Therapeutics position peaked at $738K in Q2 2024.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Scientech Research LLC's 13F filing for Q2 2026, filed 14 Aug 2026.